CRMD
Price
$13.98
Change
+$0.80 (+6.07%)
Updated
Jun 6 closing price
Capitalization
893.93M
59 days until earnings call
FULC
Price
$7.25
Change
+$0.14 (+1.97%)
Updated
Jun 6 closing price
Capitalization
383.52M
59 days until earnings call
Interact to see
Advertisement

CRMD vs FULC

Header iconCRMD vs FULC Comparison
Open Charts CRMD vs FULCBanner chart's image
CorMedix
Price$13.98
Change+$0.80 (+6.07%)
Volume$2.54M
Capitalization893.93M
Fulcrum Therapeutics
Price$7.25
Change+$0.14 (+1.97%)
Volume$388.35K
Capitalization383.52M
CRMD vs FULC Comparison Chart
Loading...
CRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRMD vs. FULC commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRMD is a StrongBuy and FULC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (CRMD: $12.43 vs. FULC: $6.90)
Brand notoriety: CRMD and FULC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRMD: 33% vs. FULC: 178%
Market capitalization -- CRMD: $893.93M vs. FULC: $383.52M
CRMD [@Biotechnology] is valued at $893.93M. FULC’s [@Biotechnology] market capitalization is $383.52M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRMD’s FA Score shows that 0 FA rating(s) are green whileFULC’s FA Score has 1 green FA rating(s).

  • CRMD’s FA Score: 0 green, 5 red.
  • FULC’s FA Score: 1 green, 4 red.
According to our system of comparison, CRMD is a better buy in the long-term than FULC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRMD’s TA Score shows that 4 TA indicator(s) are bullish while FULC’s TA Score has 3 bullish TA indicator(s).

  • CRMD’s TA Score: 4 bullish, 5 bearish.
  • FULC’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CRMD is a better buy in the short-term than FULC.

Price Growth

CRMD (@Biotechnology) experienced а +1.14% price change this week, while FULC (@Biotechnology) price change was +10.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

CRMD is expected to report earnings on Aug 07, 2025.

FULC is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRMD($894M) has a higher market cap than FULC($384M). CRMD YTD gains are higher at: 53.457 vs. FULC (46.809). FULC has higher annual earnings (EBITDA): -18.24M vs. CRMD (-47.32M). FULC has more cash in the bank: 241M vs. CRMD (46M). CRMD has less debt than FULC: CRMD (556K) vs FULC (8.63M). FULC has higher revenues than CRMD: FULC (80M) vs CRMD (12.3M).
CRMDFULCCRMD / FULC
Capitalization894M384M233%
EBITDA-47.32M-18.24M259%
Gain YTD53.45746.809114%
P/E Ratio52.72N/A-
Revenue12.3M80M15%
Total Cash46M241M19%
Total Debt556K8.63M6%
FUNDAMENTALS RATINGS
CRMD vs FULC: Fundamental Ratings
CRMD
FULC
OUTLOOK RATING
1..100
2525
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
27
Undervalued
PROFIT vs RISK RATING
1..100
57100
SMR RATING
1..100
9892
PRICE GROWTH RATING
1..100
3635
P/E GROWTH RATING
1..100
42100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FULC's Valuation (27) in the null industry is somewhat better than the same rating for CRMD (78) in the Medical Specialties industry. This means that FULC’s stock grew somewhat faster than CRMD’s over the last 12 months.

CRMD's Profit vs Risk Rating (57) in the Medical Specialties industry is somewhat better than the same rating for FULC (100) in the null industry. This means that CRMD’s stock grew somewhat faster than FULC’s over the last 12 months.

FULC's SMR Rating (92) in the null industry is in the same range as CRMD (98) in the Medical Specialties industry. This means that FULC’s stock grew similarly to CRMD’s over the last 12 months.

FULC's Price Growth Rating (35) in the null industry is in the same range as CRMD (36) in the Medical Specialties industry. This means that FULC’s stock grew similarly to CRMD’s over the last 12 months.

CRMD's P/E Growth Rating (42) in the Medical Specialties industry is somewhat better than the same rating for FULC (100) in the null industry. This means that CRMD’s stock grew somewhat faster than FULC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRMDFULC
RSI
ODDS (%)
Bearish Trend 12 days ago
83%
Bearish Trend 12 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
85%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
Bearish Trend 12 days ago
87%
Bearish Trend 12 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
87%
Bullish Trend 12 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
78%
Bullish Trend 12 days ago
87%
Advances
ODDS (%)
Bullish Trend 13 days ago
82%
Bullish Trend 21 days ago
86%
Declines
ODDS (%)
Bearish Trend 18 days ago
86%
Bearish Trend 18 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 12 days ago
78%
Bearish Trend 12 days ago
87%
Aroon
ODDS (%)
Bullish Trend 12 days ago
77%
Bullish Trend 12 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
CRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

CRMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRMD has been loosely correlated with MURA. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if CRMD jumps, then MURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRMD
1D Price
Change %
CRMD100%
-0.80%
MURA - CRMD
40%
Loosely correlated
-0.38%
HOTH - CRMD
30%
Poorly correlated
-1.43%
FULC - CRMD
30%
Poorly correlated
+8.66%
BTAI - CRMD
30%
Poorly correlated
-9.35%
OVID - CRMD
29%
Poorly correlated
-0.21%
More